Jack Nathan Medical(TSE:JNH)
CA$0.010.00 (0.00%)
TSE:JNH
Jack Nathan Medical financials statements
CA$0.01
At close:0.00 (0.00%)
Want to see TSE:JNH full AI Analyst Report?
Jack Nathan Medical (JNH) Ratios
13 Followers
Jack Nathan Medical Ratios
TSE:JNH's free cash flow for Q1 2026 was C$-1.13M. For the 2026 fiscal year, TSE:JNH's free cash flow was decreased by C$-5.00 and operating cash flow was C$-1.13M. See a summary of the company’s cash flow.
| Ratios | Apr 25 | Jan 24 | Apr 23 | Apr 22 | Apr 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.81 | 0.91 | 0.45 | 8.49 | 23.67 |
| Quick Ratio | 1.81 | 0.91 | 0.45 | 8.61 | 50.46 |
| Cash Ratio | 1.27 | 0.49 | 0.26 | 8.01 | 23.67 |
| Solvency Ratio | 3.75 | -0.32 | -0.72 | -3.42 | -567.86 |
| Operating Cash Flow Ratio | -3.69 | -0.97 | -0.36 | -0.84 | -3.87 |
| Short-Term Operating Cash Flow Coverage | -108.17 | -3.04 | -0.94 | -4.03 | -0.32 |
| Net Current Asset Value | C$ 912.15K | C$ -11.38M | C$ -5.80M | C$ 6.02M | C$ 389.59K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 1.11 | 0.71 | 0.07 | 1.75 |
| Debt-to-Equity Ratio | 0.18 | -2.08 | -2.44 | 0.08 | 1.83 |
| Debt-to-Capital Ratio | 0.16 | 1.92 | 1.70 | 0.08 | 0.65 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 2.54 | -8.24 | 0.01 | 0.32 |
| Financial Leverage Ratio | 2.68 | -1.88 | -3.45 | 1.25 | 1.04 |
| Debt Service Coverage Ratio | -12.71 | -2.06 | -2.14 | -19.13 | -39.53 |
| Interest Coverage Ratio | -39.03 | 0.00 | -12.95 | -41.29 | -37.39 |
| Debt to Market Cap | 0.01 | 3.45 | 0.56 | 0.02 | 0.01 |
| Interest Debt Per Share | 0.00 | 0.14 | 0.06 | 0.01 | 0.01 |
| Net Debt to EBITDA | 1.27 | -1.88 | -0.56 | 0.93 | -0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 84.66% | 75.62% | 76.31% | 71.84% | 97.20% |
| EBIT Margin | -27.45% | -32.04% | -42.48% | -83.54% | -266.30% |
| EBITDA Margin | -17.68% | -25.88% | -35.57% | -78.17% | -262.54% |
| Operating Profit Margin | -28.48% | -33.66% | -34.25% | -77.89% | -35.18% |
| Pretax Profit Margin | -28.88% | -38.87% | -45.13% | -85.41% | -267.26% |
| Net Profit Margin | 85.74% | -34.66% | -45.69% | -81.00% | -257.09% |
| Continuous Operations Profit Margin | -29.06% | -34.66% | -44.57% | -83.16% | -257.37% |
| Net Income Per EBT | -296.92% | 89.17% | 101.26% | 94.84% | 96.19% |
| EBT Per EBIT | 101.39% | 115.49% | 131.74% | 109.66% | 759.78% |
| Return on Assets (ROA) | 210.68% | -59.32% | -109.70% | -73.30% | -2434.50% |
| Return on Equity (ROE) | 563.81% | 111.59% | 378.90% | -91.50% | -2541.88% |
| Return on Capital Employed (ROCE) | -136.45% | -131.62% | -632.28% | -77.47% | -347.80% |
| Return on Invested Capital (ROIC) | -128.16% | -80.01% | -159.45% | -71.67% | -41.66% |
| Return on Tangible Assets | 210.68% | -64.75% | -137.20% | -82.27% | 1313.99% |
| Earnings Yield | 100.00% | -193.96% | -104.94% | -47.48% | -23.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.66 | 7.66 | 17.34 | 10.97 | 13.85 |
| Payables Turnover | 0.80 | 1.17 | 1.17 | 1.49 | 0.15 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -23.64 | -0.24 |
| Fixed Asset Turnover | 21.14 | 4.33 | 6.06 | 7.83 | 3.13 |
| Asset Turnover | 2.46 | 1.71 | 2.40 | 0.90 | 9.47 |
| Working Capital Turnover Ratio | 20.17 | -10.52 | 7.57 | 2.54 | -5.49 |
| Cash Conversion Cycle | -432.38 | -265.52 | -292.24 | -226.46 | -3956.27 |
| Days of Sales Outstanding | 23.30 | 47.66 | 21.04 | 33.29 | 26.36 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | -15.44 | -1552.87 |
| Days of Payables Outstanding | 455.68 | 313.18 | 313.29 | 244.30 | 2429.76 |
| Operating Cycle | 23.30 | 47.66 | 21.04 | 17.85 | -1526.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.07 | -0.02 | -0.01 | -0.00 |
| Free Cash Flow Per Share | -0.03 | -0.12 | -0.05 | -0.02 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -5.40 | -1.49 | -0.78 | -1.62 | -0.13 |
| Capital Expenditure Coverage Ratio | -5.40 | -1.49 | -0.78 | -1.62 | -0.13 |
| Operating Cash Flow Coverage Ratio | -26.15 | -0.49 | -0.44 | -1.13 | -0.09 |
| Operating Cash Flow to Sales Ratio | -0.73 | -0.32 | -0.13 | -0.08 | -0.02 |
| Free Cash Flow Yield | -101.03% | -298.05% | -68.08% | -7.96% | -1.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.03 | -0.52 | -0.95 | -2.11 | -4.33 |
| Price-to-Sales (P/S) Ratio | 0.86 | 0.18 | 0.44 | 1.71 | 11.12 |
| Price-to-Book (P/B) Ratio | 5.64 | -0.58 | -3.61 | 1.93 | 109.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.99 | -0.34 | -1.47 | -12.56 | -75.67 |
| Price-to-Operating Cash Flow Ratio | -1.17 | -0.56 | -3.36 | -20.32 | -644.05 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.07 | 0.08 | 0.04 | -0.09 |
| Enterprise Value Multiple | -3.58 | -2.57 | -1.78 | -1.26 | -4.27 |
| Enterprise Value | 5.51M | 12.75M | 9.83M | 9.47M | 43.16M |
| EV to EBITDA | -3.58 | -2.57 | -1.78 | -1.26 | -4.27 |
| EV to Sales | 0.63 | 0.67 | 0.63 | 0.98 | 11.20 |
| EV to Free Cash Flow | -0.73 | -1.25 | -2.14 | -7.24 | -76.21 |
| EV to Operating Cash Flow | -0.87 | -2.09 | -4.90 | -11.70 | -648.66 |
| Tangible Book Value Per Share | 0.01 | -0.08 | -0.04 | 0.09 | -0.01 |
| Shareholders’ Equity Per Share | 0.01 | -0.07 | -0.02 | 0.10 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.11 | 0.01 | 0.03 | 0.04 |
| Revenue Per Share | 0.03 | 0.22 | 0.18 | 0.12 | 0.07 |
| Net Income Per Share | 0.03 | -0.08 | -0.08 | -0.09 | -0.19 |
| Tax Burden | -2.97 | 0.89 | 1.01 | 0.95 | 0.96 |
| Interest Burden | 1.05 | 1.21 | 1.06 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.02 | 0.06 | 0.03 |
| SG&A to Revenue | 1.09 | 0.91 | 0.46 | 0.85 | 0.95 |
| Stock-Based Compensation to Revenue | 0.00 | 0.03 | 0.07 | 0.26 | 0.22 |
| Income Quality | -0.85 | 0.92 | 0.29 | 0.08 | 0.49 |
Currency in CAD

